Aug/17/2007 07:22 Filed in:
Pharma
Business
The
pharma industry is suffering a dearth of new drug
approvals thanks to an increasingly stringent
FDA, according to a report released Wednesday.
The Food and Drug Administration approved 38 new
drugs through July of this year, down 31 percent
from 55 approvals during the same period in 2006,
according to a report from James Kumpel, analyst
for Friedman, Billings, Ramsey. One has to ask if
the delays in new drug approvals is providing a
service or hurting patients? Read
More...
Tags: FDA
May/22/2007 06:44 Filed in:
Pharma
Business
In a
way Shakespeare was right...shoot all the lawyers
! Let's face it, lawyers should be thanking the
pharma industry for all the business they
getting. The latest comes from a woman in Vermont
who is suing Wyeth because the FDA approved label
"didn't go far enough". She won a $6.8 million
judgement but now it maybe up to the Supreme
Court to determine if in fact there is any
liability here. Read
More...
Tags: FDA
Apr/11/2007 06:31 Filed in:
Pharma
Business
The Food and
Drug Administration said proposed prescription
painkillers should fill an unmet medical need for
patients who have no other "relatively safer"
alternatives, suggesting Merck
& Co.'s bid
to have a Vioxx-like successor drug approved in
the U.S. faces a tough road. But who is to say
that a new drug fills an unmet medical need for
patients who have no other "relatively safer"
alternatives ? This author feels that this action
by the FDA is a dangerous precedent that could
quickly lead to major issues for consumers,
insurers and pharma companies.
Read
More...
Tags: FDA
